We are live on
!
Find out more
DGI
Disciplined Growth Investors Portfolio holdings
AUM
$4.89B
1-Year Est. Return
33.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.84%
1 Year Est. Return
+33.85%
3 Year Est. Return
+189.56%
5 Year Est. Return
+214.46%
10 Year Est. Return
+1,077.2%
AUM
$3.84B
AUM Growth
+$411M
(+12%)
Cap. Flow
+$43.2M
Cap. Flow
% of AUM
1.13%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
88
New
1
Increased
45
Reduced
40
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$4.98M |
| 2 |
Akamai
AKAM
|
+$4.48M |
| 3 |
POLY
Plantronics, Inc.
POLY
|
+$3.68M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$3.09M |
| 5 |
Intuitive Surgical
ISRG
|
+$3.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$8.93M |
| 2 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$7.7M |
| 3 |
Aviat Networks
AVNW
|
+$1.73M |
| 4 |
Liquidity Services
LQDT
|
+$1.48M |
| 5 |
Gentherm
THRM
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.21% |
| 2 | Consumer Discretionary | 21.25% |
| 3 | Industrials | 15.04% |
| 4 | Healthcare | 10.16% |
| 5 | Financials | 5.11% |
Similar funds
PBA
KCM
MCCA
FC
SCA
MCM
BMO
SIA
Disciplined Growth Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Disciplined Growth Investors held 88 positions worth $3.84B, up 12% from $3.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Trading was light in Q4 2013: portfolio turnover was 2.3%. Disciplined Growth Investors opened 1 new position and exited 1, leaving the 88-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Disciplined Growth Investors's largest Q4 2013 buy was iShares Russell Mid-Cap Growth ETF: 36,500 shares worth $1.54M.
- Disciplined Growth Investors added most to Edwards Lifesciences in Q4 2013, an estimated $4.98M increase.
- Disciplined Growth Investors's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $8.93M.
- Disciplined Growth Investors fully exited DENDREON CORPORATION in Q4 2013, selling an estimated $757K.
- Disciplined Growth Investors's ten largest holdings make up 38% of its $3.84B portfolio in Q4 2013.
- Disciplined Growth Investors opened 1 new position and closed 1 in Q4 2013.
- Disciplined Growth Investors's portfolio value rose 12% quarter-over-quarter to $3.84B.
Based on Disciplined Growth Investors's 13F filing for Q4 2013, filed 12 Feb 2014.